With more than 300 attorneys in offices in Washington, D.C. and Tennessee, Bass, Berry & Sims represents numerous publicly traded companies and Fortune 500 businesses in significant litigation, investigations, international regulatory matters, and business transactions. Our attorneys work seamlessly across substantive practice disciplines, industries and geographies to deliver highly effective service and business-focused solutions.
At Bass, Berry & Sims, delivering exceptional work is a critical part of what makes us successful. We stand apart because we all respect the contributions that our people make to the firm. We create an inclusive environment where everyone can do complex work and give their all while being themselves, irrespective of role or background. Leaving a legacy for future generations matters to us, so we always go above and beyond to exceed expectations. Read more here.
The Life Sciences Industry Practice at Bass, Berry & Sims is a comprehensive team comprised of well-established, experienced attorneys providing the highest level legal service in complementary capabilities, including corporate governance, business transactions, litigation, intellectual property, clinical research, regulatory, products liability, and compliance and government investigations. Our multidisciplinary team of 120 attorneys offers sophisticated counsel and practical solutions to resolve clients’ biggest challenges and seize their greatest opportunities. Our attorneys have represented clients in transformative, precedent-setting and award-winning life sciences matters and bring extensive experience and a deep understanding of the wide variety of commercial, compliance, and regulatory issues that the life sciences industry can face.
We serve as trusted legal and business partners providing comprehensive counsel for clients in the pharmaceutical, biotechnology, digital health and medical device sectors. We also represent the key partners helping to drive the competitive industry forward, including private equity firms, venture capitalists and other strategic investors; clinical research institutions, universities and academic medical centers; technology partners and other vendors; and healthcare providers deploying life sciences innovations around the world. Further, we help guide these same clients through the unique compliance risks facing each sector of the industry.
From companies in the start-up phase to multinational corporations, our attorneys provide strategic guidance on the broad range of matters essential to the research, development and monetization of life sciences innovation. Our team includes several attorneys with prior in-house roles including former general counsels of healthcare companies, specialty pharmacy companies, major institutions and research hospitals focused on advancing the quality of patient care through advancement in life sciences. Our team also includes a number of attorneys that held senior leadership positions for various federal regulatory agencies, including with the U.S. Department of Justice (DOJ), U.S. Department of Health and Human Services (HHS), U.S. Patent Trial and Appeal Board (PTAB), and the U.S. Securities and Exchange Commission (SEC).
The life sciences industry is poised for dramatic growth in the coming years thanks to technological advances and significant interest from outside investors. As businesses in the life sciences sector look forward to unprecedented opportunity ahead, our deep experience and diverse team offers the benefit of foresight and proactive strategy for any challenges that may arise along the way.